As of 2023, the HIV-AIDS mortality rate among females in Japan stood at a minimal level, with values projected consistently at 5 female deaths per annum from 2024 to 2028. This stability reflects a positive healthcare environment, possibly due to effective treatment regimens and comprehensive health policies. Over the years, year-on-year percentage variations appear negligible, indicating no significant fluctuation in mortality rates from 2024 onwards. The compound annual growth rate (CAGR) over the next five years remains steady at 0%, underscoring a lack of anticipated growth in the mortality rate.

Future trends to watch for:

Innovations in HIV/AIDS treatments and their accessibility across demographics.
Continuous public health awareness and prevention programs.
Monitoring any changes in policy or healthcare infrastructure that could impact mortality rates.